THEOLYTICS LTD

Active Oxford

Research and experimental development on biotechnology

24 employees website.com
Research and experimental development on biotechnology
T

THEOLYTICS LTD

Research and experimental development on biotechnology

Founded 6 Oct 2017 Active Oxford, England 24 employees website.com
Research and experimental development on biotechnology
Accounts Submitted 8 Jul 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 13 Oct 2025 Next due 19 Oct 2026 5 months remaining
Net assets £18M £9M 2024 year on year
Total assets £20M £9M 2024 year on year
Total Liabilities £2M £305K 2024 year on year
Charges 3
1 outstanding 2 satisfied

Contact & Details

Contact

Registered Address

The Sherard Building, Edmund Halley Road Oxford Science Park Oxford Oxfordshire OX4 4DQ England

Email

info@example.com

Website

www.example.com

Full company profile for THEOLYTICS LTD (11001290), an active company based in Oxford, England. Incorporated 6 Oct 2017. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2018–2024)

Cash in Bank

£17.13M

Increased by £9.46M (+123%)

Net Assets

£17.92M

Increased by £9.25M (+107%)

Total Liabilities

£1.59M

Decreased by £304.79k (-16%)

Turnover

N/A

Employees

24

Decreased by 6 (-20%)

Debt Ratio

8%

Decreased by 10 (-56%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 4
Grants 3

Investors (8)

Investor NameInvestor SinceParticipating Rounds
Investor 7Dec 2017Series B, Seed
Investor 2Jan 2021Series A, Series B
Investor 3Jan 2021Series A, Series B

Share Capital

Share Capital

Share allotments and capital structure

18 Allotments 119,505 Shares £34.88m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
28 Apr 20251,680£1.68£0.001
22 Jan 202534£658.75£19.375
3 Jan 2025110£0.11£0.001
30 Dec 202414,472£5.61m£387.5
30 Dec 20242,460£2.46£0.001

Officers

Officers

2 active 1 resigned
Status
Johan KordelDirectorSwedishSweden6427 Sept 2024Active
Noga YerushalmiDirectorIsraeliIsrael6127 Sept 2024Active

Shareholders

Shareholders (66)

Merck Ventures B.v
11.9%
17,703
Taiho Ventures Llc
11.9%
17,703

Persons with Significant Control

Persons with Significant Control (0)

0 Active 2 Ceased

Charlotte Casebourne Mills

Ceased 13 Feb 2018

Ceased
Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

1 outstanding 2 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
13 Oct 2025Confirmation StatementConfirmation statement made on 5 Oct 2025 with updates
23 Sept 2025OfficersChange to director Ms Wallace Wallace on 2 Dec 2024
23 Sept 2025OfficersChange to director Ms Wallace Lucy Elizabeth Wallace on 2 Dec 2024
8 Jul 2025AccountsAnnual accounts made up to 31 Dec 2024
29 Apr 2025CapitalAllotment of shares (GBP 149.311) on 28 Apr 2025
13 Oct 2025 Confirmation Statement

Confirmation statement made on 5 Oct 2025 with updates

23 Sept 2025 Officers

Change to director Ms Wallace Wallace on 2 Dec 2024

23 Sept 2025 Officers

Change to director Ms Wallace Lucy Elizabeth Wallace on 2 Dec 2024

8 Jul 2025 Accounts

Annual accounts made up to 31 Dec 2024

29 Apr 2025 Capital

Allotment of shares (GBP 149.311) on 28 Apr 2025

Recent Activity

Latest Activity

Confirmation statement made on 5 Oct 2025 with updates

6 months ago on 13 Oct 2025

Change to director Ms Wallace Wallace on 2 Dec 2024

7 months ago on 23 Sept 2025

Change to director Ms Wallace Lucy Elizabeth Wallace on 2 Dec 2024

7 months ago on 23 Sept 2025

Annual accounts made up to 31 Dec 2024

9 months ago on 8 Jul 2025

Allotment of shares (GBP 149.311) on 28 Apr 2025

1 years ago on 29 Apr 2025